Medical emergency?Emergency? Call 911. Nearest emergency roomsNearest ERs

Prescription medicine

Palovarotene

Official FDA data, not advice

Everything here comes from the U.S. Food and Drug Administration (FDA): the drug label, the NDC Directory, Drugs@FDA, recall reports and the drug shortage list. Each fact shows its source and date.

This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.

In an emergency, call 911. If someone may have taken too much of a medicine, call Poison Help: 1‑800‑222‑1222.

Quick answers

Is there a shortage of Palovarotene?
The FDA drug shortage list shows “To be discontinued” for a product of this medicine (updated August 31, 2026). Ask your pharmacist about alternatives.
Has Palovarotene been recalled?
No recall linked to the products of this medicine appears in the FDA enforcement reports we use.
Who makes Palovarotene?
1 company lists prescription products of Palovarotene in the FDA NDC Directory, including Ipsen Biopharmaceuticals, Inc..

What Palovarotene is used for

We did not find an “Indications and Usage” section in the FDA labels for this medicine.

This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.

Forms and how it is given

Dosage formsCapsule
RouteOral
Prescription products5 in the FDA NDC Directory
Brand namesSohonos

Companies that list this medicine

Labelers in the FDA NDC Directory: the company named on the package (maker or distributor), with the number of prescription products.

FDA approval history

  • NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
Brand and biologic applications
ApplicationSponsorApprovedLater changes approved
NDA215559
SOHONOS
IpsenAugust 16, 2023 2, latest September 18, 2026
2026: Labeling · 2025: Efficacy

Shortage status

To be discontinued · updated August 31, 2026 · first posted August 31, 2026

ProductSOHONOS, Capsule, 2.5 mg (NDC 15054-0025-1)
CompanyIpsen Biopharmaceuticals, Inc.

Ask your pharmacist whether your product is affected and what the options are.

FDA Drug Shortages database →

Recalls

No recall linked to these products (by their NDC code) appears in the FDA enforcement reports.

Official identifiers

FDA labels (SPL)0
FDA applicationsNDA215559
Active ingredients (FDA)PALOVAROTENE

Sources

  1. NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  2. Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  3. Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
  4. Drug shortages (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026

openFDA data is provided by the FDA as is; it may be incomplete. Always rely on the label that comes with your medicine. FDA Enforcement Report search →

Report an error → · Information for medicine makers